Dr. Jou, Yuh-Shan 周玉山 博士



  • Somatic A-to-I RNA-edited RHOA isoform 2 specific-R176G mutation promotes tumor progression in lung adenocarcinoma
    Molecular Carcinogenesis, Dec 01, 2022
          Adenosine-to-inosine (A-to-I) RNA editing is the most common posttranscriptional editing to create somatic mut ......
    MORE 更多
  • Prognostic comparative genes predict targets for sorafenib combination therapies in hepatocellular carcinoma
    Comput Struct Biotechnol J, Apr 20, 2022
          With the increasing incidence and mortality of human hepatocellular carcinoma (HCC) worldwide, revealing innov ......
    MORE 更多
  • PSPC1 is a new contextual determinant of aberrant subcellular translocation of oncogenes in tumor progression
    Journal of Biomedical Science, Aug 02, 2021
        Dysregulation of nucleocytoplasmic shuttling is commonly observed in cancers and emerging as a cancer hallmark for the d ......
    MORE 更多
  • PSPC1 Potentiates IGF1R Expression to Augment Cell Adhesion and Motility
    Cells, Jun 18, 2020
    Abstract Paraspeckle protein 1 (PSPC1) overexpression in cancers is known to be the pro-metastatic switch of tumor progression associat ......
    MORE 更多
  • Integrative analyses of noncoding RNAs reveal the potential mechanisms augmenting tumor malignancy in lung adenocarcinoma
    Nucleic Acids Research, Dec 19, 2019
    Precise noncoding RNA (ncRNA)-based network prediction is necessary to reveal ncRNA functions and pathological mechanisms. Here, we establis ......
    MORE 更多

List of Highlights